1.
E. Kerboua1, Z.Benlahrech2, R.Benyahia3. Sorafenib in iodo-refractory thyroid cancer : Experience of medical oncology department of Pierre and Marie Curie Center Algiers Algeria . ijmscrr [Internet]. 2024 May 16 [cited 2024 Dec. 22];7(03):Page: 494-496. Available from: http://ijmscrr.in/index.php/ijmscrr/article/view/792